Accepted for Publication: October 9, 2013.
Published Online: January 29, 2014. doi:10.1001/jamadermatol.2013.9026.
Study concept and design: Wieczorek, Werth.
Acquisition of data: Wieczorek, Okawa, Werth.
Analysis and interpretation of data: Wieczorek, Propert, Werth.
Drafting of the manuscript: Wieczorek.
Critical revision of the manuscript for important intellectual content: Wieczorek, Propert, Okawa, Werth.
Statistical Analysis: Wieczorek, Propert.
Obtained funding: Werth.
Administrative, technical, and material support: Okawa, Werth.
Study supervision: Werth.
Conflict of Interest Disclosures: None reported.
Funding/Support: This study was supported in part by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development) and by the National Institutes of Health (grant NIH K24-AR 02207) (Dr Werth); and The Lupus Foundation of America, Philadelphia Tri-State Chapter (Dr Wieczorek).
Role of the Sponsor: The funding agencies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: Aileen Chang, MD, Elizabeth Ghazi, MD, and Saroj Verma, MD, collected data and provided feedback.
Additional Information: The copyright for the CLASI (CLE Disease Activity and Severity Index), a data source used in this study, is owned by the University of Pennsylvania.